- 专利标题: Myopia control means
-
申请号: US15416674申请日: 2017-01-26
-
公开(公告)号: US10156737B2公开(公告)日: 2018-12-18
- 发明人: Aldo Abraham Martinez , Arthur Ho , Padmaja Rajagopal Sankaridurg , Percy Fabian Lazon , Brien Anthony Holden , Rick Payor , Gregor F. Schmid
- 申请人: Novartis AG , Brien Holden Vision Institute
- 申请人地址: CH Basel AU Sydney
- 专利权人: Novartis AG,Brien Holden Vision Institute
- 当前专利权人: Novartis AG,Brien Holden Vision Institute
- 当前专利权人地址: CH Basel AU Sydney
- 代理商 Robert A. Ambrose
- 优先权: AU2008901921 20080418
- 主分类号: G02C7/02
- IPC分类号: G02C7/02 ; G02C7/06 ; G02C7/04 ; A61B3/00 ; G02C13/00
摘要:
Sets, kits or stocks of anti-myopia lenses and methods for their use, that do not require a clinician to measure peripheral refractive error in the eyes of myopic patients. Lenses having peripheral powers or defocus set in accordance with central corrective power will cover almost all normal myopes not worse than −6D central refractive error. For example, a kit or set of lenses (50, FIG. 15) can have multiple parts or sub-sets each with a compartmented container with lenses arranged according to increments of central corrective power. The lenses of the first part have four steps of peripheral power or defocus to provide therapeutic effect and, while the lenses of the second part also have four steps, the level of therapeutic effect is higher. Other examples of sets, kits and stocks, as well as examples of lenses themselves, are disclosed together with methods of use.
公开/授权文献
- US20170146824A1 MYOPIA CONTROL MEANS 公开/授权日:2017-05-25
信息查询